CA Stock MarketDetailed Quotes

MDMA Pharmala Biotech Holdings Inc

Watchlist
  • 0.110
  • +0.005+4.76%
15min DelayMarket Closed Jul 23 15:48 ET
10.02MMarket Cap-13750P/E (TTM)

Pharmala Biotech Holdings Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
(Q3)May 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-94.49%40.35K
-69.49%222.85K
-77.11%195.04K
-77.11%195.04K
-58.70%495.99K
-60.42%731.72K
-65.98%730.47K
-65.53%852.14K
--852.14K
--1.2M
-Cash and cash equivalents
-94.49%40.35K
-69.49%222.85K
-77.11%195.04K
-77.11%195.04K
-58.70%495.99K
-60.42%731.72K
-65.98%730.47K
-65.53%852.14K
--852.14K
--1.2M
-Accounts receivable
85.68%112.95K
68.45%123.68K
739.76%194.96K
739.76%194.96K
--0
-35.97%60.83K
--73.43K
--23.22K
--23.22K
----
Total current assets
-32.74%681.56K
-35.27%647.47K
-34.23%713.95K
-34.23%713.95K
-42.58%828.5K
-50.68%1.01M
-55.25%1M
-57.13%1.09M
--1.09M
--1.44M
Non current assets
-Accumulated depreciation
-62.60%-4.4K
-74.65%-3.98K
-91.38%-3.55K
-91.38%-3.55K
-116.18%-3.13K
-170.03%-2.7K
-310.07%-2.28K
-512.87%-1.86K
---1.86K
---1.45K
-Goodwill
30.28%1.8M
28.88%1.74M
36.72%1.7M
36.72%1.7M
74.69%1.44M
135.37%1.38M
334.98%1.35M
378.12%1.24M
--1.24M
--824.26K
-Other intangible assets
----
----
----
----
----
-54.14%87.26K
0.00%190.27K
-93.27%190.27K
--190.27K
--190.27K
Regulatory assets
361.92%395.01K
127.10%285.39K
342.11%223.49K
342.11%223.49K
-60.18%27.91K
-29.12%85.52K
56.72%125.67K
-15.15%50.55K
--50.55K
--70.1K
Total assets
268.53%76.24K
-3.17%46.71K
5.13%24.53K
5.13%24.53K
-63.82%23.91K
-4.41%20.69K
-36.68%48.24K
-58.02%23.33K
--23.33K
--66.1K
Liabilities
Current liabilities
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Current deferred liabilities
18.56%399.07K
-12.24%283.19K
750.55%443.32K
750.55%443.32K
--387.58K
7,827.23%336.59K
7,501.32%322.68K
--52.12K
--52.12K
----
Current liabilities
50.98%1.14M
26.64%878K
142.82%1.03M
142.82%1.03M
171.51%812.35K
56.49%753.89K
417.80%693.3K
206.03%423.78K
--423.78K
--299.2K
Non current liabilities
Non current accrued expenses
-57.30%1.26K
-50.41%1.67K
-44.67%2.1K
-44.67%2.1K
-39.90%2.53K
-36.56%2.95K
-33.80%3.38K
60.70%3.8K
--3.8K
--4.21K
Regulatory liabilities
---16.86K
---16.86K
----
----
----
----
----
----
----
----
Total non current liabilities
50.98%1.14M
26.64%878K
142.82%1.03M
142.82%1.03M
171.51%812.35K
56.49%753.89K
417.80%693.3K
206.03%423.78K
--423.78K
--299.2K
Shareholders'equity
Share capital
8.90%5.26M
8.90%5.26M
6.37%5.14M
6.37%5.14M
6.37%5.14M
0.00%4.83M
0.00%4.83M
120.03%4.83M
--4.83M
--4.83M
-common stock
8.90%5.26M
8.90%5.26M
6.37%5.14M
6.37%5.14M
6.37%5.14M
0.00%4.83M
0.00%4.83M
120.03%4.83M
--4.83M
--4.83M
Additional paid-in capital
-8.56%399.73K
-18.28%343.14K
-0.74%376.36K
-0.74%376.36K
46.32%371.09K
82.80%437.15K
103.73%419.9K
165.85%379.15K
--379.15K
--253.61K
Total equity
3.52%2.48M
1.48%2.39M
3.54%2.41M
3.54%2.41M
-0.02%2.27M
-9.41%2.4M
-7.77%2.35M
-16.60%2.33M
--2.33M
--2.27M
(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022(Q3)May 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -94.49%40.35K-69.49%222.85K-77.11%195.04K-77.11%195.04K-58.70%495.99K-60.42%731.72K-65.98%730.47K-65.53%852.14K--852.14K--1.2M
-Cash and cash equivalents -94.49%40.35K-69.49%222.85K-77.11%195.04K-77.11%195.04K-58.70%495.99K-60.42%731.72K-65.98%730.47K-65.53%852.14K--852.14K--1.2M
-Accounts receivable 85.68%112.95K68.45%123.68K739.76%194.96K739.76%194.96K--0-35.97%60.83K--73.43K--23.22K--23.22K----
Total current assets -32.74%681.56K-35.27%647.47K-34.23%713.95K-34.23%713.95K-42.58%828.5K-50.68%1.01M-55.25%1M-57.13%1.09M--1.09M--1.44M
Non current assets
-Accumulated depreciation -62.60%-4.4K-74.65%-3.98K-91.38%-3.55K-91.38%-3.55K-116.18%-3.13K-170.03%-2.7K-310.07%-2.28K-512.87%-1.86K---1.86K---1.45K
-Goodwill 30.28%1.8M28.88%1.74M36.72%1.7M36.72%1.7M74.69%1.44M135.37%1.38M334.98%1.35M378.12%1.24M--1.24M--824.26K
-Other intangible assets ---------------------54.14%87.26K0.00%190.27K-93.27%190.27K--190.27K--190.27K
Regulatory assets 361.92%395.01K127.10%285.39K342.11%223.49K342.11%223.49K-60.18%27.91K-29.12%85.52K56.72%125.67K-15.15%50.55K--50.55K--70.1K
Total assets 268.53%76.24K-3.17%46.71K5.13%24.53K5.13%24.53K-63.82%23.91K-4.41%20.69K-36.68%48.24K-58.02%23.33K--23.33K--66.1K
Liabilities
Current liabilities
-Total tax payable --0--0--0--0--0--0--0--0--0--0
Current deferred liabilities 18.56%399.07K-12.24%283.19K750.55%443.32K750.55%443.32K--387.58K7,827.23%336.59K7,501.32%322.68K--52.12K--52.12K----
Current liabilities 50.98%1.14M26.64%878K142.82%1.03M142.82%1.03M171.51%812.35K56.49%753.89K417.80%693.3K206.03%423.78K--423.78K--299.2K
Non current liabilities
Non current accrued expenses -57.30%1.26K-50.41%1.67K-44.67%2.1K-44.67%2.1K-39.90%2.53K-36.56%2.95K-33.80%3.38K60.70%3.8K--3.8K--4.21K
Regulatory liabilities ---16.86K---16.86K--------------------------------
Total non current liabilities 50.98%1.14M26.64%878K142.82%1.03M142.82%1.03M171.51%812.35K56.49%753.89K417.80%693.3K206.03%423.78K--423.78K--299.2K
Shareholders'equity
Share capital 8.90%5.26M8.90%5.26M6.37%5.14M6.37%5.14M6.37%5.14M0.00%4.83M0.00%4.83M120.03%4.83M--4.83M--4.83M
-common stock 8.90%5.26M8.90%5.26M6.37%5.14M6.37%5.14M6.37%5.14M0.00%4.83M0.00%4.83M120.03%4.83M--4.83M--4.83M
Additional paid-in capital -8.56%399.73K-18.28%343.14K-0.74%376.36K-0.74%376.36K46.32%371.09K82.80%437.15K103.73%419.9K165.85%379.15K--379.15K--253.61K
Total equity 3.52%2.48M1.48%2.39M3.54%2.41M3.54%2.41M-0.02%2.27M-9.41%2.4M-7.77%2.35M-16.60%2.33M--2.33M--2.27M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg